Anti-CD11 alpha/Integrin alpha-L [YTH 81.5]

Absolute Antibody

Anti-CD11 alpha/Integrin alpha-L [YTH 81.5]

9

Recognizes a 180kD glycoprotein, CD11 alpha, expressed by human leukocytes, involved in cellular adhesion and costimulatory signaling. It is the target of the drug efalizumab.

Flow Cytometry

Research Use Only

Monoclonal

YTH 81.5

ITGAL

integrin subunit alpha L

antigen CD11A (p180), lymphocyte function-associated antigen 1, alpha polypeptide; CD11 antigen-like family member A; CD11A; integrin alpha-L; integrin gene promoter; integrin, alpha L (antigen CD11A (p180), lymphocyte function-associated antigen 1; alpha polypeptide); leukocyte adhesion glycoprotein LFA-1 alpha chain; leukocyte function-associated molecule 1 alpha chain; LFA-1; LFA-1 alpha; LFA1A; LFA-1A; lymphocyte function-associated antigen 1, alpha polypeptide

Mouse

IgG1

Integrin alpha-L

This chimeric mouse antibody was made using the variable domain sequences of the original Rat IgG2b format, for improved compatibility with existing reagents, assays and techniques.

Human

-20°C,2°C to 8°C

12352203